Littérature scientifique sur le sujet « Modelli in vivo »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Modelli in vivo ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Modelli in vivo"
Slade, Arietta, et Jeremy Holmes. « Attaccamento e psicoterapia ». QUADERNI DI PSICOTERAPIA COGNITIVA, no 45 (janvier 2020) : 13–24. http://dx.doi.org/10.3280/qpc45-2019oa8985.
Texte intégralCasarosa, Federica, et Marco Gobbato. « Forma e funzioni delle reti di imprese : evidenze da una ricerca nel settore vitivinicolo ». ECONOMIA E SOCIETÀ REGIONALE, no 3 (mars 2011) : 61–91. http://dx.doi.org/10.3280/es2010-003009.
Texte intégralTagliagambe, Silvano. « Il Metaverso come ambiente e risorsa ». EDUCAZIONE SENTIMENTALE, no 37 (septembre 2022) : 28–42. http://dx.doi.org/10.3280/eds2022-037003.
Texte intégralKlein, Silvan, Thiha Aung, Robert Michael Haas, Fabian Medved, Stefan M. Schiller, Oliver Felthaus et Jürgen H. Dolderer. « Tissue Engineering von Fettgewebe mittels bioabbaubaren Biomaterialien zur Weichteildefektdeckung ». Handchirurgie · Mikrochirurgie · Plastische Chirurgie 50, no 02 (avril 2018) : 83–92. http://dx.doi.org/10.1055/s-0043-115117.
Texte intégralZORBOZAN, Orçun, Mehmet HARMAN, Vedat EVREN, Mümin Alper ERDOĞAN, Aslı KILAVUZ, Varol TUNALI, İbrahim ÇAVUŞ, Özlem YILMAZ, Ahmet ÖZBİLGİN et Nevin TURGAY. « Glia Hücrelerinin Antimona Dirençli Leishmania tropica ile Enfekte Edilmesi : Yeni Bir ex-vivo Modeli ». Mikrobiyoloji Bulteni 52, no 1 (15 janvier 2018) : 49–55. http://dx.doi.org/10.5578/mb.66350.
Texte intégralWeigand, Annika, Kereshmeh Tasbihi, Pamela Strissel, Reiner Strick, Raymund Horch et Anja Boos. « Entwicklung eines neuen Zellisolationsverfahrens zur Erforschung der Mammakarzinompathogenese und -angiogenese für experimentelle in vitro und in vivo Assays ». Handchirurgie · Mikrochirurgie · Plastische Chirurgie 49, no 02 (avril 2017) : 111–22. http://dx.doi.org/10.1055/s-0042-123706.
Texte intégralGinoux, Jean-Marc. « Il paradosso del modello PREDATORE-PREDA di Vito Volterra ». Lettera Matematica Pristem 102, no 1 (octobre 2017) : 54–62. http://dx.doi.org/10.1007/s10031-017-0043-5.
Texte intégralKöhrmann, K., J. Bensemann, F. Kahmann, A. Weber, J. Florian, Ch Bührle, J. Teubner, J. Rassweiler et P. Alken. « Die stoßwellen-induzierte Gefäßläsion am Ex-vivo-Modell der isolierten, perfundierten Schweineniere ». Aktuelle Urologie 25, no 05 (septembre 1994) : 298–304. http://dx.doi.org/10.1055/s-2008-1058243.
Texte intégralMichel, R. Th, G. Bastert, H. P. Fortmeyer, D. Isner et H. Schmidt-Matthiesen. « Die Interpretation von Hormonrezeptorbefunden. Untersuchungen mit dem in vivo-Modell der Nacktmaus ». Archives of Gynecology 238, no 1-4 (septembre 1985) : 572–73. http://dx.doi.org/10.1007/bf02430105.
Texte intégralGunter, T., B. Merz, R. Merieske-Stern, J. Schmitt, R. Leppek et M. Lengesfeld. « Zahnimplantattestung am In-vivo-Finite-Elemente-Modell - Testing of Dental Implants Using an in vivo Finite Element Model ». Biomedizinische Technik/Biomedical Engineering 45, no 10 (2000) : 272–76. http://dx.doi.org/10.1515/bmte.2000.45.10.272.
Texte intégralThèses sur le sujet "Modelli in vivo"
FARAVELLI, GIULIA. « Meccanismi molecolari dell'amiloidosi sistemica : modelli in vitro e in vivo ». Doctoral thesis, Università degli studi di Pavia, 2019. http://hdl.handle.net/11571/1301267.
Texte intégralSystemic amyloidosis is a fatal disease caused by misfolding of native globular proteins that then aggregate extracellularly as insoluble fibrils, damaging structure and function of affected organs. My PhD project has been designed to address the crucial question of the mechanism of globular to fibrillary conversion of two amyloidogenic proteins, transthyretin (TTR) and β2-microglobulin (β2-m), in conditions that closely resemble the physiological environment. For those reasons, I have been trying to combine in vitro and in vivo methods in order to get a general and broadest comprehension of the process that leads toward the deposition of amyloid fibrils. Wild-type TTR is intrinsically amyloidogenic and tends to form microscopic and clinically silent amyloid deposits in the heart, in the lungs and in the blood vessels wall of the majority of elderly people, causing Senile systemic amyloidosis (SSA). Over 100 mutations codify for protein variants of the WT TTR, causing familial amyloidosis, although they have a rare incidence. Firstly, I investigated the inhibition of transthyretin isoforms by small ligands. The study was based on the discovery of the previously unrecognised mechano enzymatic mechanism in which shear stress and proteolysis play a key role towards the formation of amyloid fibrils. This pathway of aggregation is efficiently inhibited only by ligands that occupy both binding sites in TTR. Mds84, a bivalent ligand of TTR superstabiliser family, has shown to be more potent than the monovalent ligands probably because of its additional interactions of its linker within the TTR central channel. Secondly, I have been actively involved in the identification of the putative protease responsible for proteolysis of transthyretin in vivo. In a comprehensive bioinformatics search for systemically active proteases with tryptic specificity, plasmin was selected as the leading candidate. Indeed, plasmin selectively cleaves TTR in vitro, releasing full length and truncated protomers that rapidly aggregate via nucleation and elongation into genuine amyloid fibrils. Finally, I carried out a comparative analysis of the thermodynamic stability of natural and in vitro made TTR fibrils. The second protein that I studied was β2-m. WT β2-m is associated with the amyloidosis of patients under chronic haemodialytic treatment; known as dialysis-related amyloidosis, but in the presence of a specific mutation (D76N β2-m) causes a familial form of systemic amyloidosis. Recently C. elegans, a nematode model well suited to the investigation of age-related diseases, was used in order to establish three transgenic lines expressing the wild type and two highly amyloidogenic forms, but the expression of the D76N variant was not possible with this system. Therefore, the smg-1 temperature sensitive strain was engineered, in order to express the protein variant only at higher temperatures. Using the INVertebrate Automated Phenotyping Platform (INVAPP) and an algorithm, Paragon, we were able to rapidly detect growth and motility impairment in D76N β2-m expressing worms that were incubated at 25°C. Moreover, the INVAPP/Paragon system enabled demonstration of the efficacy of doxycycline, a drug able to inhibit β2-m fibrillogenesis both in vitro and in vivo. Thus, a useful C. elegans model for D76N β2-m related amyloidosis has been developed and the INVAPP/Paragon system provides a powerful tool with which to undertake high-throughput screening in the search for candidates able to combat amyloid-induced toxicity. Indeed, using the automated system for C. elegans phenotyping, a library-scale screening was performed and 11 molecules, which are interactors of protein-protein complexes, have been selected for their ability to revert the defective phenotype of transgenic worms expressing Aβeta1-42 peptide.
CHIORAZZI, ALESSIA. « Studio della neurotossicità periferica indotta da farmaci antitubulinici in modelli sperimentali in vitro e in vivo ». Doctoral thesis, Università degli Studi di Milano-Bicocca, 2010. http://hdl.handle.net/10281/18017.
Texte intégralCAVAGNINI, MIRIAM. « STUDIO IN VIVO DEL RUOLO DEGLI iMSN NELLA CODIFICA DELL’ATTIVITÀ MOTORIA IN MODELLI MURINI MEDIANTE CALCIUM IMAGING ». Doctoral thesis, Università degli studi di Modena e Reggio Emilia, 2022. http://hdl.handle.net/11380/1273445.
Texte intégralStriatum is the main input nucleus of the basal ganglia and 95% of its neurons are GABAergic Medium Spiny Neurons (MSNs). MSNs are subdivided into neurons of the direct and indirect pathway. The direct pathway consists of MSNs (direct MSNs, dMSNs) mainly expressing dopamine D1 receptors (D1R), whereas MSNs of the indirect pathway (iMSNs) express dopamine D2 receptor (D2R) and adenosine A2A receptor (A2AR) [Gerfen et al., 1990; Gerfen et al., 1992; Gong et al. 2003]. According to the classical model, these two pathways exert an opposite effect on movement regulation: the direct pathway promotes activity of the cortex that codes a motor plan, and therefore movement initiation, while the indirect pathway inhibits cortical activity and movement [Albin et al., 1989; Alexander and Crutcher, 1990; DeLong 1990]. Recent studies have challenged this interpretation and demonstrated that both pathways are co-activated during movement initiation but with differential activities [Bonnavion et al., 2019; Tecuapetla et al., 2016]. Yet, while the role of these two pathways is globally understood, cell-specific mechanisms and their interaction in relation to movement control are only partially known. Modern technological advances such as calcium (Ca2+) imaging techniques can be applied to directly observe the neuronal activity in these two pathways. During periods of heightened neural activity, Ca2+ flows into the dendritic branches and cell bodies of neurons, increasing its intracellular concentrations. These activity-dependent fluctuations in intracellular Ca2+ can be monitored by expressing a Ca2+ indicator, such as GCaMP, into the neuronal population of interest. The aim of this study was to investigate the role of murine striatum in locomotion, and in particular the involvement of iMSNs, using recent in vivo Ca2+ imaging technologies. Locomotor activity was tested by behavioural experiments and the GABAergic iMSN activity was stimulated by a psychostimulant drug, d-Amphetamine, at different doses. In this study, in vivo calcium imaging was used to visualize striatal neural circuit dynamics of the indirect pathway during mouse behaviour with head-mounted microscopes and chronically implanted endoscopes. A2AGCaMPs mice expressing GCaMP in iMSNs were used as an animal model. Behavioural analysis showed that acute intraperitoneal injection of d-Amphetamine at 3 mg/kg dose markedly increases locomotor activity with a peak 15 minutes after injection, while a dose of d-Amphetamine at 1 mg/kg modestly decreases locomotor activity, possibly due to the induction of stereotyped behaviour. Traces of iMSN calcium activity were extracted from the imaging data and analysed with custom developed software. The results showed a significant decrease in the average number of active iMSNs and a significant increase in the average spike duration after d-Amphetamine 3 mg/kg injection. At 1mg/kg dose, there was a trend for a significant decrease in the average number of active cells and a significant increase in the average spike duration. Analysis of the acquired datasets showed how iMSNs encode movement, confirming previous results reported by Parker and colleagues [Parker et al, 2018]. In detail, the analysis revealed that iMSN activity rises around 0.5-0.7 seconds before motion onset and falls around 1-0.5 seconds before motion offset, suggesting that increased firing of iMSNs encodes locomotion. However, it is not clear whether movement or rest are encoded by changes in the activity of randomly distributed iMSNs or specific sub-sets of iMSNs change their activity during rest or movement. This study allows us to better understand the complexity of MSN activity, challenging the classical view where the direct and indirect pathway show an opposite pattern of activity during movement.
DA, SACCO LETIZIA. « Analisi dei profili di espressione di microRNA applicata a modelli sperimentali in vitro e in vivo ». Doctoral thesis, Università degli Studi di Roma "Tor Vergata", 2010. http://hdl.handle.net/2108/1381.
Texte intégralOver the last decade, the discovery of microRNAs revealed a new mechanism of post-transcriptional regulation. MicroRNAs are involved in many biological processes such as development, differentiation, proliferation and cell death. Moreover, several evidences showed the pathogenic role of microRNAs in various diseases. A lot of studies used microarray technology to identify miRNAs involved in the pathogenesis, but also to obtain the expression pattern characteristic of pathology with diagnostic or prognostic assessment. These studies suggest that profiling of microRNAs may be used to understand the role they play in regulating pathophysiological processes. In this work we employed microarray technology to investigate the expression profile of microRNAs in two different experimental models: 1) an in vitro model, useful for understanding the molecular mechanisms underlying the immune response, 2) a in vivo model, suitable for studying the pathogenesis of non-alcoholic fatty liver disease, also known as NAFLD. Recently, has been explored the relationship between inflammation, innate immunity and microRNAs, which are described to be involved in regulating cellular response to microbial infection. Thus, we identified the specific expression profile of microRNAs in human dendritic cells, using an in vitro model of stimulation and activation by agonists of different Toll-like Receptors (TLRs): R848/Resiquimod, ligand of TLR7/8; LPS, ligand of TLR4; and poly(I: C), ligand of TLR3. Analysis of expression profiles identified groups of miRNAs expressed specifically in response to treatments with LPS, R848, or their combination with respect to control dendritic cells. This analysis will help to clarify their possible role in mechanisms of dendritic cells to discriminate pathogens. The non-alcoholic fatty liver disease or NAFLD is an emerging disease characterized by a wide spectrum of liver conditions from simple steatosis, steatohepatitis with or without fibrosis (NASH, non-alcoholic steatohepatitis). The etiopathogenesis of NAFLD is complex and still unclear. To identify possible molecular mechanisms involved in the development of NAFLD, we used an animal model, able to reproduce various aspects of human pathology. In this study we performed the analysis of microRNAs expression profiles in liver tissue of rats subjected to different diets. Our results showed that treatment with different ipercaloric regimens caused a significant increase in body weight and liver, and some metabolic parameters, compared to control animals, as well as different liver damage. The analysis of microRNAs showed the significant downregulation of three microRNAs (miR-122, miR-451 and miR-27a) and the up-regulation of other three microRNAs (miR-200A, miR-429 and miR-200B) in animals treated with ipercaloric diets respect to those with a standard diet. Among the potential targets of these microRNAs we found some molecules involved in the regulation of apoptosis and inflammation, but also intracellular signaling proteins, and lipid and glucose metabolism.
METO, AIDA. « Approcci innovativi per studi sui patogeni del cavo orale : modelli di studio in vitro ed ex vivo ». Doctoral thesis, Università degli studi di Modena e Reggio Emilia, 2021. http://hdl.handle.net/11380/1246163.
Texte intégralDuring recent years, novel compounds/tools are being proposed to maintain oral health and/or to treat dental/periodontal problems. As well known, dental caries are among the most diffused infections and their improper management turns towards relevant disease(s) and eventually tooth extraction. Extensive literature documents the pathogenic role of certain microorganisms and their ability to persist in the oral cavity, as a complex microbial community, including bacteria, viruses and fungi, tightly enclosed in a polymeric matrix of polysaccharide origin. Such sessile community, and particularly dental plaque, the first deeply studied human-associated biofilm, is notoriously refractory not only to common cleaning procedures by mouthwashes and tooth-pastes/brushes, but also to antimicrobial drugs and host immune defenses. This scenario becomes further complicated considering that the widely diffused orthodontic treatments, with fixed or removal brackets, extend the clinical challenge, being such devices an additional good habitat for microbial adhesion, growth and biofilm formation. To a similar extent, patients with dental implants may locally develop biofilm-related diseases, allowing clinical progression toward pathogen-related peri-mucositis or peri-implantitis. From here, the need arises for innovative tools/compounds to facilitate microbial removal and maintenance of oral cavity homeostasis. Besides the most investigated oral pathogens, including Streptococcus mutans-group and the “red complex” Gram-negative anaerobe bacilli, also Candida albicans (C. albicans), Staphylococcus aureus (S. aureus) and Pseudomonas aeruginosa (P. aeruginosa) may occur as causative agent of oral diseases. The first, often harbored as commensal of healthy mucosae, is the main fungal pathogen involved in oral mucositis. The latter two are subtle pathogens, responsible of wide-spectrum diseases; they are being extensively used for in vitro studies, because of their numerous virulence factors and wide-spectrum antimicrobial resistance. The aim of the present thesis was to evaluate in vitro and ex vivo, the antimicrobial and antibiofilm efficacy of innovative approaches against oral pathogens. Our data provided in vitro and ex vivo evidence on the antimicrobial efficacy of several dental-care compounds. A novel use of the endodontic product Cupral could be proposed in daily hygiene practices. The Bic-40 treatment was shown as the best approach in cleaning smooth and rough titanium surfaces (without altering their properties); importantly, its device-decontamination efficacy did not affect the biological properties of reparative stem cells. Furthermore, our work added new insights on the anti-microbial properties of a natural compound, such as propolis, and on its possible mechanisms of action. At last, we showed that the Biorepair Peribioma toothpaste and gum deeply affected oral microorganisms’ behavior, drastically impairing their ability to contaminate and produce plaque onto orthodontic devices; interestingly, replacement by beneficial microorganisms was observed. The overall take-home message from this research is that basic science may greatly increase our knowledge on how to counteract biofilm-producing pathogens; in turn, this will facilitate prevention and/or treatment of dental and oral biofilm-associated infections, making a huge difference in terms of health promotion.
CUTULI, Marco Alfio. « Modelli preclinici non convenzionali : vantaggi, limiti e applicabilità della proof of concept agli aspetti regolatori ». Doctoral thesis, Università degli studi del Molise, 2021. http://hdl.handle.net/11695/100701.
Texte intégralNew global regulations and greater ethical conscience lead to stronger controls on the use of vertebrates in pre-clinical studies. To overcome the significant costs and time required to obtain authorisation for mammalian studies, alternative animal models have been proposed in recent years to reduce the utilisation of vertebrates. Three non-conventional pre-clinical models were proposed and tested in the present work to evaluate in vivo activity and toxicity of chemical and biological substances. Promising results were obtained from the Lepidoptera Galleria mellonella, which proved to be a reliable pre-clinical model for screening natural antimicrobial substances, probiotics, and the host-parasite relationship. Encouraging data were also observed using the Coleoptera Tenebrio molitor as a potential model of intestinal inflammation. In addition, the snail species Limacus flavus was developed as an in vivo mucosal model to assess the irritant potential of chemicals. Although the proposed models have some limitations, they have proven to be effective for rapid and reproducible pre-clinical screening. These assays do not require sophisticated instruments and are aligned with current legislation on the protection of animals used for scientific purposes.
PANNELLA, Micaela. « Valutazione degli effetti del Dexametasone e del Cisplatino nei modelli sperimentali in vitro (OC-k3)e in vivo(Ratti Wistar) ». Doctoral thesis, Università degli studi di Ferrara, 2011. http://hdl.handle.net/11392/2388742.
Texte intégralMarchi, Enrica <1977>. « Pralatrexate sinergizza in vitro ed in vivo con l'inibitore del Proteosoma Bortezomib in modelli pre-clinici di Linfoma Non Hodkin T ». Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2010. http://amsdottorato.unibo.it/2430/1/Tesi.pdf.
Texte intégralMarchi, Enrica <1977>. « Pralatrexate sinergizza in vitro ed in vivo con l'inibitore del Proteosoma Bortezomib in modelli pre-clinici di Linfoma Non Hodkin T ». Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2010. http://amsdottorato.unibo.it/2430/.
Texte intégralBAZZINI, CHIARA. « STUDY OF MOLECULAR MECHANISMS AND NEW STRATEGIES AGAINST A CYTOTOXICITY AND NEUROINFLAMMATION IN EX VIVO CELLULAR MODELS FROM ALZHEIMER’S DISEASE PATIENTS ». Doctoral thesis, Università degli Studi di Milano-Bicocca, 2021. http://hdl.handle.net/10281/306480.
Texte intégralAlzheimer's disease (AD) is a major public health concern and has been identified as a priority for research in Life Science. The two core pathological hallmarks of AD are extracellular amyloid plaques and intracellular neurofibrillary tangles which underlie microglial and neuronal damage, neuroinflammation and cognitive impairment. Soluble oligomers are the most toxic species of β-amyloid (Aβ) and interact with several protein kinases such as Ras/MAPK and PI3K/AKT pathways, which regulate many cellular processes and cognitive functions. These pathways mediate Aβ toxicity, regulating some molecular mechanisms involved in neuronal degeneration such as cytoskeletal impairment, glutamate excitotoxicity and neuroinflammation. In the last years much attention has been focused on the potential role of natural compounds as neuroprotective agents. Hop (Humulus Lupulus) contains flavonoids, aromatic molecules which have antioxidant, anti-inflammatory and anti-atherogenic properties. In fact, hop extract has anti-aggregating effects on Aβ, and it seems to prevent its production in cultured cells. Aβ induces also the activation of the pattern recognition receptor Nod-like receptor protein 3 (NLRP3) inflammasome complex in microglia and the consequent release of proinflammatory cytokines, playing a pivotal role in AD-associated neuroinflammation. NLRP3 activation results in the release of inflammatory mediators, including ASC protein complexes (ASC specks), IL-1β and IL-18, that facilitate Aβ deposition and neuroinflammation in a self-feeding pathogenic loop. Since specific therapeutical strategies are still lacking, the dampening of the inflammasome assembly and activation could be a new strategy for AD. The overall focus of this study is to investigate molecular mechanisms involved in neurodegenerative diseases and in neuroinflammation, using peripheral ex vivo cellular models from AD, to check new potential therapeutical targets. In order to characterize the complex interactions among Aβ, MAPK and AKT signaling, we used fibroblasts from sporadic AD patients with different disease severity. To evaluate any molecular mechanisms that could prevent or modulate Aβ-induced toxicity, the potential cytoprotective effects of Hop extract and related intracellular signaling were also investigated. Fibroblasts provide a useful cellular model for studying AD, since they could be differentiated into patient-specific neural cell lines, using iPSC technologies. Moreover, particular interest was given to NLRP3-inflammasome activation pathway. We investigated the involvement of NLRP3 inflammasome activation on intracellular pathways and their downstream targets, using a combination of in vitro studies and patient-derived samples. In particular, we used macrophage-derived THP-1 human monocytes and peripheral blood mononuclear cells (PBMC)-derived monocytes from healthy control (HC) subjects and AD patients, to analyse phagocytosis, autophagy and apoptosis modulation and the effects of the nucleoside reverse transcriptase inhibitor Stavudine (D4T), that reduces NLRP3 inflammasome activation blocking the purinergic receptor P2X7R. Furthermore, we analyzed the NLRP3 inflammasome pathway and the role of the selective NLRP3 inhibitor CRID3, to compare the effects of inflammasome inhibition through two different mechanisms. At this purpose, HC and AD-derived monocytes were differentiated into microglia-like cells (MDMIs) and characterized for myeloid surface and intracellular proteins expression. Key microglia functions such as inflammatory cytokines release, Aβ phagocytosis and degradation were evaluated upon exposure to NLRP3 inflammasome activators with or without CRID3. MDMIs reflected many features of microglia and, as fibroblasts-derived iPSCs, they are attractive cellular models helpful to understand AD pathogenesis, identify therapeutic targets and allow large-scale drug screening of the novel therapeutic candidates.
Livres sur le sujet "Modelli in vivo"
1974-, Stevenson Christopher S., Morgan Douglas W. 1951- et Marshall Lisa A. 1954-, dir. In vivo models of inflammation. 2e éd. Basel : Birkhäuser, 2006.
Trouver le texte intégral1951-, Morgan Douglas W., et Marshall Lisa A. 1954-, dir. In vivo models of inflammation. Basel : Birkhauser Verlag, 1999.
Trouver le texte intégralNtziachristos, Vasilis. Textbook of in vivo imaging in vertebrates. Chichester, West Sussex : J. Wiley, 2007.
Trouver le texte intégralvan, Boxtel Christoffel Jos, Holford N. H. G et Danhof M, dir. The In vivo study of drug action. Amsterdam : Elsevier, 1992.
Trouver le texte intégral1953-, Raeburn D., et Giembycz M. A. 1961-, dir. Airways smooth muscle : Modelling the asthmatic response in vivo. Basel : Birkhäuser Verlag, 1996.
Trouver le texte intégralInternational Symposium on Nephrotoxicity (3rd 1987 University of Surrey). Nephrotoxicity : In vitro to in vivo : animals to man. New York : Plenum Press, 1989.
Trouver le texte intégralFerrick, David A. Transgenic mice as a in vivo model for self reactivity. Austin : R.G. Landes Co., 1994.
Trouver le texte intégralC, Sahu Saura, et Casciano Daniel, dir. Nanotoxicity : In vivo and in vitro models to health risks. Chichester, West Sussex : John Wiley & Sons, 2009.
Trouver le texte intégralC, Sahu Saura, dir. Hepatotoxicity : From genomics to in vitro and in vivo models. Chichester, England : John Wiley & Sons, 2007.
Trouver le texte intégralMuseo del vino (Torgiano, Italy), dir. Bozzetti, modelli e grisailles dal XVI al XVIII secolo : Fondazione Lungarotti, Torgiano, Museo del Vino, 28 ottobre-20 novembre 1988. Milano : Electa, 1988.
Trouver le texte intégralChapitres de livres sur le sujet "Modelli in vivo"
Carlson, Richard P., et Peer B. Jacobson. « Comparison of adjuvant and streptococcal cell wall-induced arthritis in the rat ». Dans In Vivo Models of Inflammation, 1–50. Basel : Birkhäuser Basel, 1999. http://dx.doi.org/10.1007/978-3-0348-7775-6_1.
Texte intégralWeringer, Elora J., et Ronald P. Gladue. « T cell-mediated diseases of immunity ». Dans In Vivo Models of Inflammation, 237–63. Basel : Birkhäuser Basel, 1999. http://dx.doi.org/10.1007/978-3-0348-7775-6_10.
Texte intégralOrosz, Charles G., M. Elaine Wakely, Ginny L. Bumgardner et Elora J. Weringer. « Transplantation ». Dans In Vivo Models of Inflammation, 265–90. Basel : Birkhäuser Basel, 1999. http://dx.doi.org/10.1007/978-3-0348-7775-6_11.
Texte intégralGrass, David S. « Transgenics ». Dans In Vivo Models of Inflammation, 291–305. Basel : Birkhäuser Basel, 1999. http://dx.doi.org/10.1007/978-3-0348-7775-6_12.
Texte intégralAnderson, Karen M., Sandhya S. Nerurkar et Michael R. Briggs. « Gene transfer technology ». Dans In Vivo Models of Inflammation, 307–32. Basel : Birkhäuser Basel, 1999. http://dx.doi.org/10.1007/978-3-0348-7775-6_13.
Texte intégralLitwak, Kenneth N., et Howard C. Hughes. « Guidelines and regulations in animal experimentation ». Dans In Vivo Models of Inflammation, 333–36. Basel : Birkhäuser Basel, 1999. http://dx.doi.org/10.1007/978-3-0348-7775-6_14.
Texte intégralvan den Berg, Wim B., et Leo A. B. Joosten. « Murine collagen-induced arthritis ». Dans In Vivo Models of Inflammation, 51–75. Basel : Birkhäuser Basel, 1999. http://dx.doi.org/10.1007/978-3-0348-7775-6_2.
Texte intégralLewis, E. Jonathan, Jill Bishop et Anna K. Greenham. « Joint and cartilage degradation ». Dans In Vivo Models of Inflammation, 77–92. Basel : Birkhäuser Basel, 1999. http://dx.doi.org/10.1007/978-3-0348-7775-6_3.
Texte intégralWinkler, James D., Jeffrey R. Jackson, Tai-Ping Fan et Michael P. Seed. « Angiogenesis ». Dans In Vivo Models of Inflammation, 93–109. Basel : Birkhäuser Basel, 1999. http://dx.doi.org/10.1007/978-3-0348-7775-6_4.
Texte intégralSelig, William M., et Richard W. Chapman. « Asthma ». Dans In Vivo Models of Inflammation, 111–35. Basel : Birkhäuser Basel, 1999. http://dx.doi.org/10.1007/978-3-0348-7775-6_5.
Texte intégralActes de conférences sur le sujet "Modelli in vivo"
Deka, Dhyanjyoti, Paul R. Hays, Kamaldev Raghavan et Mike Campbell. « Straked Riser Design With VIVA ». Dans ASME 2010 29th International Conference on Ocean, Offshore and Arctic Engineering. ASMEDC, 2010. http://dx.doi.org/10.1115/omae2010-20569.
Texte intégralCheng, Yongming, Lixin Xu, Kostas F. Lambrakos et Karl Muriby. « Investigation of VIV Fatigue Prediction for a Top Tensioned Riser ». Dans ASME 2009 28th International Conference on Ocean, Offshore and Arctic Engineering. ASMEDC, 2009. http://dx.doi.org/10.1115/omae2009-79508.
Texte intégralHönzke, K., D. Fatykhova, M. Tönnies, TT Bauer, P. Schneider, J. Neudecker, JC Rückert et al. « Das ex vivo Modell der humanen Lunge in der Pneumonieforschung ». Dans Pneumonie & Co : Lungeninfektionen in Klinik und Forschung – 22. Workshop des Arbeitskreises ‚Respiratorisches System‘ der Deutschen Veterinärmedizinischen Gesellschaft (DVG) in Kooperation mit der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DPG). Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1692847.
Texte intégralDraf, CS, E. Chavez, K. Pak, A. Leichtle, S. Dazert et AF Ryan. « Ein In-vivo-Modell als potenzieller Therapieansatz für geräuschinduzierten Haarzellverlust ». Dans Abstract- und Posterband – 91. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Welche Qualität macht den Unterschied. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1711815.
Texte intégralMoore, J. A., D. A. Steinman, S. J. Karlik, B. K. Rutt, D. W. Holdsworth et C. R. Ethier. « Accuracy Assessment of Computational Blood Flow Modelling in Realistic Arterial Geometries ». Dans ASME 1998 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 1998. http://dx.doi.org/10.1115/imece1998-0061.
Texte intégralTietz, U., C. C. Berndt et K. P. Schmitz. « Microstructural Modelling and Performance Simulation of Engineered Bio-Composites ». Dans ITSC2010, sous la direction de B. R. Marple, A. Agarwal, M. M. Hyland, Y. C. Lau, C. J. Li, R. S. Lima et G. Montavon. DVS Media GmbH, 2010. http://dx.doi.org/10.31399/asm.cp.itsc2010p0516.
Texte intégralWallin, Ake, et Kaj Klaue. « Three-Dimensional In Vivo Modelling And Evaluation Of Hip Coverage ». Dans Biostereometrics '88 : Fifth Intl Mtg, sous la direction de Juerg U. Baumann et Robin E. Herron. SPIE, 1989. http://dx.doi.org/10.1117/12.950466.
Texte intégralBaldi, Gabriele, Andrea Cafarelli, Raffaele Bisogno, Stefania Vetrano et Leonardo Ricotti. « Modelling of in vivo LIPUS stimulation of murine intestinal wall ». Dans 2021 IEEE International Ultrasonics Symposium (IUS). IEEE, 2021. http://dx.doi.org/10.1109/ius52206.2021.9593434.
Texte intégralOwen, John R., et Jennifer S. Wayne. « Influence of Loading Conditions and the Superficial Tangential Zone in Contact Models of Articular Surfaces ». Dans ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-206143.
Texte intégralCardamone, Luca, Arturo Valentin et Jay D. Humphrey. « Modelling Dynamical Arterial Adaptations to Altered Chemo-Mechanical Environments ». Dans ASME 2008 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2008. http://dx.doi.org/10.1115/sbc2008-192097.
Texte intégralRapports d'organisations sur le sujet "Modelli in vivo"
Nepom, Gerald T. Humanized in vivo Model for Autoimmune Diabetes. Fort Belvoir, VA : Defense Technical Information Center, février 2010. http://dx.doi.org/10.21236/ada523882.
Texte intégralNepom, Gerald T., et John A. Gebe. Humanized in vivo Model for Autoimmune Diabetes. Fort Belvoir, VA : Defense Technical Information Center, février 2009. http://dx.doi.org/10.21236/ada625335.
Texte intégralNepom, Gerald T., et John A. Gebe. Humanized in vivo Model for Autoimmune Diabetes. Fort Belvoir, VA : Defense Technical Information Center, février 2008. http://dx.doi.org/10.21236/ada482199.
Texte intégralHayward, Simon W. A Myc-Driven in Vivo Model of Human Prostate Cancer. Fort Belvoir, VA : Defense Technical Information Center, octobre 2007. http://dx.doi.org/10.21236/ada495670.
Texte intégralHayward, Simon V. A Myc-Driven in Vivo Model of Human Prostate Cancer. Fort Belvoir, VA : Defense Technical Information Center, octobre 2008. http://dx.doi.org/10.21236/ada502009.
Texte intégralHayward, Simon W. A Myc-Driven in Vivo Model of Human Prostate Cancer. Fort Belvoir, VA : Defense Technical Information Center, octobre 2005. http://dx.doi.org/10.21236/ada446297.
Texte intégralBorgstrom, Per, et John Welsh. Ovarian Tumor-Stroma Interactions in an In Vivo Orthotopic Model. Fort Belvoir, VA : Defense Technical Information Center, août 2012. http://dx.doi.org/10.21236/ada580971.
Texte intégralHayward, Simon W. A Myc-Driven in Vivo Model of Human Prostate Cancer. Fort Belvoir, VA : Defense Technical Information Center, octobre 2006. http://dx.doi.org/10.21236/ada465209.
Texte intégralBorgstrom, Per. Ovarian Tumor-Stroma Interactions in an In Vivo Orthotopic Model. Fort Belvoir, VA : Defense Technical Information Center, août 2011. http://dx.doi.org/10.21236/ada554643.
Texte intégralHayward, Simon W. A Myc-Driven in Vivo Model of Human Prostate Cancer. Fort Belvoir, VA : Defense Technical Information Center, octobre 2007. http://dx.doi.org/10.21236/ada482533.
Texte intégral